Riktkurs.nu
EN | SV
Stockholm Stock Exchange
Elekta
+18.09% (9.65)
+22.46% (11.98)
Goldman SachsSEBNordeaSB1 MarketsJP MorganDNB CarnegieBarclaysCitigroupJefferiesMorgan StanleyMorningstarCarnegieBernsteinDeutsche BankKepler CheuvreuxSEB EquitiesDNBDNB MarketsABG Sundal CollierNordea MarketsDanske BankDanske Bank MarketsHandelsbankenHandelsbanken Capital Markets

Latest Target

+18.09%
63.00 SEK

Three Month Consensus

+22.46%
65.33 SEK

All Price Targets For Elekta

Goldman Sachs
63.00 SEK
+18.09%
SEB
SEB
Mar 6
68.00 SEK
+27.46%
Nordea
Nordea
Mar 6
65.00 SEK
+21.84%
SB1 Markets
59.00 SEK
+10.59%
JP Morgan
JP Morgan
Dec -25
52.00 SEK
-2.53%
DNB Carnegie
65.00 SEK
+21.84%
Barclays
Barclays
Nov -25
46.00 SEK
-13.78%
Citigroup
Citigroup
Jun -25
39.00 SEK
-26.90%
Jefferies
Jefferies
Jun -25
53.00 SEK
-0.66%
Morgan Stanley
55.00 SEK
+3.09%
Morningstar
108.00 SEK
+102.44%
Carnegie
Carnegie
Feb -25
70.00 SEK
+31.21%
Bernstein
Bernstein
Jan -25
69.00 SEK
+29.33%
Deutsche Bank
70.00 SEK
+31.21%
Kepler Cheuvreux
71.00 SEK
+33.08%
SEB Equities
76.00 SEK
+42.46%
DNB
DNB
Jun -24
76.00 SEK
+42.46%
DNB Markets
90.00 SEK
+68.70%
ABG Sundal Collier
120.00 SEK
+124.93%
Nordea Markets
100.00 SEK
+87.44%
Danske Bank
72.00 SEK
+34.96%
Danske Bank Markets
93.00 SEK
+74.32%
Handelsbanken
135.00 SEK
+153.05%
Handelsbanken Capital Markets
150.00 SEK
+181.16%

About The Company

Elekta AB is a Swedish company that mainly manufactures the beam knife Leksell Gamma Knife for the treatment of tumors. The company is founded by neurosurgeon Lars Leksell and springs from his and physicist Börje Larsson’s work to treat brain tumors using gamma radiation.
Wikipedia